Question 1

What is Charcot-Marie-Tooth disease type 4B3?

Accepted Answer

Charcot-Marie-Tooth disease type 4B3 is a form of inherited peripheral neuropathy that primarily affects the motor and sensory nerves, leading to muscle weakness, atrophy, and sensory loss. This condition is caused by pathogenic variants in the SBF1 gene and typically presents in childhood. Although the disease is characterized by demyelinating features such as reduced nerve conduction velocity and folded myelin structures seen on nerve biopsy, its overall prevalence is very rare, affecting fewer than 1 in 1 million people. The clinical severity and range of symptoms can vary widely between affected individuals.

Question 2

What are the symptoms of Charcot-Marie-Tooth disease type 4B3?

Accepted Answer

The clinical picture of Charcot-Marie-Tooth disease type 4B3 is dominated by a demyelinating sensorimotor neuropathy. Characteristic features include persistent skeletal muscle atrophy, muscle fibrillations, and both distal lower limb and upper limb muscle weakness, with almost all individuals exhibiting these signs. In addition, patients consistently show decreased nerve conduction velocities, sensory impairment, the presence of myelin outfoldings, and onion bulb formations on nerve biopsy, all of which underscore the underlying nerve pathology. Some individuals also experience additional problems such as scoliosis, loss of ambulation, ophthalmoplegia, urinary incontinence, brain atrophy, syndactyly, and strabismus, although these are less frequently observed. Not all individuals experience every feature, and the severity of symptoms varies considerably.

Question 3

What causes Charcot-Marie-Tooth disease type 4B3?

Accepted Answer

Charcot-Marie-Tooth disease type 4B3 results from pathogenic variants in the SBF1 gene, which is essential for normal nerve function and myelin maintenance. The condition follows an autosomal recessive inheritance pattern, meaning that an affected individual inherits one altered copy of the gene from each parent. This pattern implies that both parents are typically carriers, even though they do not show symptoms. It is more commonly observed when parents share a common ancestor, as this increases the likelihood that both carry the same rare genetic change. Genetic counseling is recommended to help families understand the inheritance pattern and consider options for family planning. Associated genes include SBF1.

Question 4

How is Charcot-Marie-Tooth disease type 4B3 inherited?

Accepted Answer

Charcot-Marie-Tooth disease type 4B3 follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is Charcot-Marie-Tooth disease type 4B3?

Accepted Answer

Charcot-Marie-Tooth disease type 4B3 is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is Charcot-Marie-Tooth disease type 4B3 diagnosed?

Accepted Answer

The definitive diagnosis of Charcot-Marie-Tooth disease type 4B3 is made through molecular genetic testing that identifies pathogenic variants in the SBF1 gene. In addition to genetic testing, a clinical evaluation that considers the characteristic features such as reduced nerve conduction velocity and demyelinating findings on nerve biopsy is important for supporting the diagnosis. Because many of the features of this condition may overlap with other neuromuscular disorders, genetic confirmation is essential to distinguish it from similar conditions.

Question 7

Are there treatments for Charcot-Marie-Tooth disease type 4B3?

Accepted Answer

Currently, management of Charcot-Marie-Tooth disease type 4B3 focuses on supportive care and symptom management, as there are no approved treatments or established foundational therapies specific to this condition. Treatment is tailored to the individual and typically involves a multidisciplinary team that may include neurologists, physical therapists, and orthopedic specialists. Regular surveillance is an essential part of long-term care, with ongoing monitoring helping to identify complications such as progressive muscle weakness or skeletal abnormalities before they become severe. Genetic counseling is also recommended to support affected individuals and their families in understanding the condition and exploring available care options.

Question 8

Are there clinical trials for Charcot-Marie-Tooth disease type 4B3?

Accepted Answer

Yes, there is currently 1 active clinical trial for Charcot-Marie-Tooth disease type 4B3 registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 9

Where can I find support for Charcot-Marie-Tooth disease type 4B3?

Accepted Answer

Patient advocacy organizations for Charcot-Marie-Tooth disease type 4B3 include Hunters cmt4b3 Research Foundation Inc. These organizations can provide information, connect you with other families, and help navigate care. Visit the Support section of this page for full details and contact information.

Question 10

What are the potential complications of Charcot-Marie-Tooth disease type 4B3?

Accepted Answer

Charcot-Marie-Tooth disease type 4B3 can lead to various complications, including progressive muscle weakness and skeletal abnormalities like scoliosis. Some individuals may also experience loss of ambulation, which can affect mobility and independence. Regular monitoring by healthcare professionals is important to identify and manage these complications early.

Question 11

How does Charcot-Marie-Tooth disease type 4B3 affect daily life and activities?

Accepted Answer

Living with Charcot-Marie-Tooth disease type 4B3 can impact daily activities due to muscle weakness and sensory loss. Individuals may find it challenging to perform tasks that require fine motor skills or balance. Supportive care, including physical therapy and assistive devices, can help improve mobility and maintain independence in daily life.

Question 12

What is the prognosis for someone with Charcot-Marie-Tooth disease type 4B3?

Accepted Answer

The prognosis for individuals with Charcot-Marie-Tooth disease type 4B3 varies widely. Some may experience a slowly progressing neuropathy with stable periods, while others might face increasing functional challenges over time. Access to specialized care and ongoing management can help support quality of life as individuals grow into adulthood.

Organ System	Phenotype Count	Example Features
Muscles	7	Skeletal muscle atrophy, Upper limb muscle weakness, Brain atrophy
Brain and nerves	3	Difficulty walking (gait disturbance), Brain atrophy, Intellectual disability
Arms and legs	3	Upper limb muscle weakness, Distal lower limb muscle weakness, Lower limb muscle weakness
Bones and joints	2	Skeletal muscle atrophy, Sideways curvature of the spine (scoliosis)
Head and neck	1	Microcephaly
Eyes	1	Strabismus
Kidneys and urinary system	1	Urinary incontinence

Kisho

Charcot-Marie-Tooth disease type 4B3

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Patient Support

Patient Advocacy Groups

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Latest News & Developments

Clinical and pathological findings in two Italian siblings of Romani ancestry with charcot-marie-tooth type 4D and review of the current literature.

Novel genetic and nerve imaging characterization of Charcot-Marie-Tooth disease type 4F.

Patient journey with Charcot-Marie-Tooth Disease - A German patient survey study.

Charcot-Marie-Tooth disease type 4B3

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Patient Support

Patient Advocacy Groups

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is Charcot-Marie-Tooth disease type 4B3?

What are the symptoms of Charcot-Marie-Tooth disease type 4B3?

What causes Charcot-Marie-Tooth disease type 4B3?

How is Charcot-Marie-Tooth disease type 4B3 inherited?

How rare is Charcot-Marie-Tooth disease type 4B3?

How is Charcot-Marie-Tooth disease type 4B3 diagnosed?

Are there treatments for Charcot-Marie-Tooth disease type 4B3?

Are there clinical trials for Charcot-Marie-Tooth disease type 4B3?

Where can I find support for Charcot-Marie-Tooth disease type 4B3?

What are the potential complications of Charcot-Marie-Tooth disease type 4B3?

How does Charcot-Marie-Tooth disease type 4B3 affect daily life and activities?

What is the prognosis for someone with Charcot-Marie-Tooth disease type 4B3?

Latest News & Developments

Clinical and pathological findings in two Italian siblings of Romani ancestry with charcot-marie-tooth type 4D and review of the current literature.

Novel genetic and nerve imaging characterization of Charcot-Marie-Tooth disease type 4F.

Patient journey with Charcot-Marie-Tooth Disease - A German patient survey study.